![Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: Results of a randomized double-blind trial - ScienceDirect Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: Results of a randomized double-blind trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S001650850401234X-gr1.jpg)
Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: Results of a randomized double-blind trial - ScienceDirect
![Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016 Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016](https://journals.sagepub.com/cms/10.1177/0300060516628704/asset/images/large/10.1177_0300060516628704-fig1.jpeg)
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016
![Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet](https://www.thelancet.com/cms/attachment/2000988127/2003634384/gr1.gif)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/3-Figure1-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016 Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016](https://journals.sagepub.com/cms/10.1177/0300060516628704/asset/images/large/10.1177_0300060516628704-fig2.jpeg)
Celecoxib versus diclofenac for the treatment of ankylosing spondylitis: 12-week randomized study in Norwegian patients - Chris Walker, Margaret N Essex, Chunming Li, Peter W Park, 2016
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet](https://www.thelancet.com/cms/attachment/b77ebcde-64a9-4932-80c7-16627a6b631a/gr1.gif)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison - The Lancet
![Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbf40210606e2a1de2e6ed64d6621eb468e1db48/3-Table1-1.png)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar
![Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study - ScienceDirect Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002934305009137-gr2.jpg)
Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study - ScienceDirect
![Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis | Arthritis Research & Therapy | Full ... Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis | Arthritis Research & Therapy | Full ...](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13075-015-0554-0/MediaObjects/13075_2015_554_Fig3_HTML.gif)
Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis | Arthritis Research & Therapy | Full ...
![NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same? | Journal of Pharmacology and Experimental Therapeutics NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same? | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/348/1/86/F5.large.jpg)
NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same? | Journal of Pharmacology and Experimental Therapeutics
![Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | Drug Safety Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | Drug Safety](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40264-022-01211-1/MediaObjects/40264_2022_1211_Fig1_HTML.png)
Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials | Drug Safety
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/3-Table2-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial - Payam Mohammadinejad, Pantea Arya, Mohsen Esfandbod, Ahmad Kaviani, Masoome Najafi, Ladan Kashani ... Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial - Payam Mohammadinejad, Pantea Arya, Mohsen Esfandbod, Ahmad Kaviani, Masoome Najafi, Ladan Kashani ...](https://journals.sagepub.com/cms/10.1177/1060028015592215/asset/images/large/10.1177_1060028015592215-fig2.jpeg)
Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial - Payam Mohammadinejad, Pantea Arya, Mohsen Esfandbod, Ahmad Kaviani, Masoome Najafi, Ladan Kashani ...
![Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c58926c84106ede737c42a0756a97ac424fadec6/4-Table4-1.png)
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison | Semantic Scholar
![Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbf40210606e2a1de2e6ed64d6621eb468e1db48/5-Table3-1.png)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar
![Oral celecoxib versus oral diclofenac for post‐perineal repair analgesia after spontaneous vaginal birth: A randomised trial - LIM - 2008 - Australian and New Zealand Journal of Obstetrics and Gynaecology - Wiley Online Library Oral celecoxib versus oral diclofenac for post‐perineal repair analgesia after spontaneous vaginal birth: A randomised trial - LIM - 2008 - Australian and New Zealand Journal of Obstetrics and Gynaecology - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/37d2d249-c72c-4d0d-88df-7bc642609fd7/ajo_808_f1.gif)
Oral celecoxib versus oral diclofenac for post‐perineal repair analgesia after spontaneous vaginal birth: A randomised trial - LIM - 2008 - Australian and New Zealand Journal of Obstetrics and Gynaecology - Wiley Online Library
Effect of neostigmine with diclofenac or celecoxib on kidney function... | Download Scientific Diagram
![Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2001011244/2003796220/gr1.gif)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet
![Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbf40210606e2a1de2e6ed64d6621eb468e1db48/4-Table2-1.png)